Yunfeng Shen

662 total citations
29 papers, 309 citations indexed

About

Yunfeng Shen is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Yunfeng Shen has authored 29 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Yunfeng Shen's work include Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). Yunfeng Shen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). Yunfeng Shen collaborates with scholars based in China and South Korea. Yunfeng Shen's co-authors include Guohua Yang, Yun Zhuang, Wei Xu, Jianyong Li, Lei Yang, Hai‐Rong Qiu, Jianyong Li, Xin Zhou, Ri Zhang and Yi Li and has published in prestigious journals such as Blood, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Yunfeng Shen

26 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunfeng Shen China 12 111 101 96 66 64 29 309
Adina Aviram Israel 11 206 1.9× 71 0.7× 51 0.5× 34 0.5× 60 0.9× 20 397
Alice Melão Portugal 10 154 1.4× 88 0.9× 46 0.5× 91 1.4× 29 0.5× 13 381
Guowei Dai China 9 268 2.4× 156 1.5× 55 0.6× 39 0.6× 28 0.4× 18 451
Weilai Xu China 8 203 1.8× 172 1.7× 72 0.8× 36 0.5× 24 0.4× 41 383
Ann K. Strege United States 5 196 1.8× 62 0.6× 213 2.2× 106 1.6× 118 1.8× 9 388
Laurie Iciek United States 5 218 2.0× 129 1.3× 57 0.6× 70 1.1× 20 0.3× 7 407
Bruce A. Silver United States 8 117 1.1× 34 0.3× 83 0.9× 31 0.5× 33 0.5× 15 296
Xiangjie Lin China 11 213 1.9× 66 0.7× 58 0.6× 36 0.5× 32 0.5× 31 396
Antonieta Chávez‐González Mexico 13 161 1.5× 178 1.8× 72 0.8× 48 0.7× 15 0.2× 37 402
Weiguo Xiao China 14 120 1.1× 62 0.6× 28 0.3× 142 2.2× 30 0.5× 33 468

Countries citing papers authored by Yunfeng Shen

Since Specialization
Citations

This map shows the geographic impact of Yunfeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfeng Shen more than expected).

Fields of papers citing papers by Yunfeng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunfeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfeng Shen. The network helps show where Yunfeng Shen may publish in the future.

Co-authorship network of co-authors of Yunfeng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yunfeng Shen. A scholar is included among the top collaborators of Yunfeng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunfeng Shen. Yunfeng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yongbo, Xingyu Liu, Panpan Xia, et al.. (2022). The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases. Frontiers in Immunology. 13. 901166–901166. 5 indexed citations
2.
Shen, Yunfeng, et al.. (2016). Thermodynamics and Structural Evolution during a Reversible Vesicle–Micelle Transition of a Vitamin-Derived Bolaamphiphile Induced by Sodium Cholate. Journal of Agricultural and Food Chemistry. 64(9). 1977–1988. 22 indexed citations
3.
Cheng, Feng, et al.. (2016). Preclinical evaluation of WYE-687, a mTOR kinase inhibitor, as a potential anti-acute myeloid leukemia agent. Biochemical and Biophysical Research Communications. 470(2). 324–330. 7 indexed citations
4.
Yang, Lei, et al.. (2015). Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia. PLoS ONE. 10(5). e0126601–e0126601. 20 indexed citations
5.
Shen, Yunfeng, et al.. (2015). HIF-α Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression. Cell Biochemistry and Biophysics. 72(1). 179–183. 24 indexed citations
6.
Shen, Yunfeng, et al.. (2015). Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(4). 531–534. 15 indexed citations
7.
Cao, Songyu, Guohua Yang, Juan Zhang, et al.. (2015). Replication analysis confirms the association of several variants with acute myeloid leukemia in Chinese population. Journal of Cancer Research and Clinical Oncology. 142(1). 149–155. 3 indexed citations
8.
Zhuang, Yun, Chun Qiao, Guohua Yang, et al.. (2014). [FcγRIII a polymorphisms and efficacy of Rituximab combined chemotherapy for diffuse large B-cell lymphoma in Chinese patients].. PubMed. 35(9). 816–21. 1 indexed citations
9.
Yang, Guohua, et al.. (2014). Ganoderma lucidumpolysaccharide exerts anti-tumor activity via MAPK pathways in HL-60 acute leukemia cells. Journal of Receptors and Signal Transduction. 36(1). 6–13. 34 indexed citations
10.
Cao, Songyu, Guohua Yang, Yun Pan, et al.. (2013). Potentially Functional Polymorphism in IL-23 Receptor and Risk of Acute Myeloid Leukemia in a Chinese Population. PLoS ONE. 8(2). e55473–e55473. 14 indexed citations
11.
Xia, Jun, et al.. (2012). JAK2 V617F, MPL W515L and JAK2 exon 12 mutations in Chinese patients with primary myelofibrosis. Chinese Journal of Cancer Research. 24(1). 72–76. 8 indexed citations
12.
Zhou, Xiaojuan, Sujiang Zhang, Chun Qiao, Yunfeng Shen, & Jianyong Li. (2011). [Isocitrate dehydrogenase gene mutations in acute myeloid leukemia].. PubMed. 19(4). 902–6. 1 indexed citations
13.
Guo, Hongfeng, Xin Zhou, Guohua Yang, et al.. (2010). Bortezomib plus intermediate‐dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: A Chinese experience. American Journal of Hematology. 85(7). 499–501. 8 indexed citations
14.
Zhuang, Yun, Wei Xu, Yunfeng Shen, & Jianyong Li. (2010). Fcγ Receptor Polymorphisms and Clinical Efficacy of Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 10(5). 347–352. 12 indexed citations
15.
Shen, Yunfeng, Xin Zhou, Zhi Wang, et al.. (2010). Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma. Leukemia Research. 35(2). 147–151. 14 indexed citations
17.
Zhu, Yu, Jianyong Li, Wei Xu, et al.. (2007). [Multiplex fluorescence in situ hybridization for detecting complex chromosomal aberrations in chronic myeloid leukemia in blast crisis].. PubMed. 28(7). 458–61. 1 indexed citations
18.
Wu, Wei, et al.. (2007). [The prognostic significance of derivative chromosome 9 deletions in chronic myeloid leukemia].. PubMed. 46(5). 386–8. 1 indexed citations
19.
Xu, Wei, Jianyong Li, Jinlan Pan, et al.. (2007). Interphase Fluorescence In Situ Hybridization Detection of Cytogenetic Abnormalities in B-Cell Chronic Lymphocytic Leukemia. International Journal of Hematology. 85(5). 430–436. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026